{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:33:03Z","timestamp":1787671983074,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Institute for Respiratory Health Western Australia Glenn Brown Memorial Award 2020"},{"name":"Cystic Fibrosis Western Australia Golf PhD Top Up Scholarship 2020"},{"name":"Australian Government Research Training Program (RTP) Scholarship"},{"DOI":"10.13039\/501100001801","name":"University of Western Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001801","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40271-026-00806-5","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T16:54:57Z","timestamp":1774112097000},"page":"673-686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recalibration: Exploring the Impact of Elexacaftor\/Tezacaftor\/Ivacaftor on Self-Concept for Adults with Cystic Fibrosis"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-2708","authenticated-orcid":false,"given":"Maggie","family":"Harrigan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Jessup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Bacopanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhain","family":"Mulrennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"issue":"6","key":"806_CR1","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/ppul.26954","volume":"59","author":"J Guo","year":"2024","unstructured":"Guo J, King I, Hill A. International disparities in diagnosis and treatment access for cystic fibrosis. Pediatr Pulmonol. 2024;59(6):1622\u201330.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"806_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","volume":"8","author":"SC Bell","year":"2020","unstructured":"Bell SC, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020;8(1):65\u2013124.","journal-title":"Lancet Respir Med"},{"issue":"12","key":"806_CR3","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/thoraxjnl-2014-205983","volume":"69","author":"AL Quittner","year":"2014","unstructured":"Quittner AL, et al. Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of the International Depression Epidemiological Study across nine countries. Thorax. 2014;69(12):1090\u20137.","journal-title":"Thorax"},{"issue":"1","key":"806_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jcf.2020.07.020","volume":"20","author":"MS Schechter","year":"2021","unstructured":"Schechter MS, et al. Decreased survival in cystic fibrosis patients with a positive screen for depression. J Cyst Fibros. 2021;20(1):120\u20136.","journal-title":"J Cyst Fibros"},{"issue":"5","key":"806_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurpra.2023.104585","volume":"19","author":"A Gulledge","year":"2023","unstructured":"Gulledge A, Miller S, Newman SD, Mueller M, Christon L, Flume PA. Social isolation among adults living with cystic fibrosis in the United States: a single-center experience. J Nurse Pract. 2023;19(5):104585.","journal-title":"J Nurse Pract"},{"issue":"2","key":"806_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jcf.2024.01.005","volume":"23","author":"PR Burgel","year":"2024","unstructured":"Burgel PR, et al. Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues. J Cyst Fibros. 2024;23(2):187\u2013202.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"806_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jcf.2024.05.007","volume":"23","author":"A Gramegna","year":"2024","unstructured":"Gramegna A, et al. Standards for the care of people with cystic fibrosis (CF); planning for a longer life. J Cyst Fibros. 2024;23(3):375\u201387.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"806_CR8","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jcf.2023.05.002","volume":"22","author":"E Landau","year":"2023","unstructured":"Landau E. Cystic fibrosis in a transformative era: adapting to changing mental health needs. J Cyst Fibros. 2023;22(3):372\u20133.","journal-title":"J Cyst Fibros"},{"issue":"12","key":"806_CR9","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S2213-2600(24)00205-4","volume":"12","author":"GM Solomon","year":"2024","unstructured":"Solomon GM, et al. Evaluation of elexacaftor-tezacaftor-ivacaftor treatment in individuals with cystic fibrosis and CFTR(N1303K) in the USA: a prospective, multicentre, open-label, single-arm trial. Lancet Respir Med. 2024;12(12):947\u201357.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"806_CR10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/MCP.0000000000000727","volume":"26","author":"T Havermans","year":"2020","unstructured":"Havermans T, Duff AJA. Changing landscape: psychological care in the era of cystic fibrosis transmembrane conductance regulator modulators. Curr Opin Pulm Med. 2020;26(6):696\u2013701.","journal-title":"Curr Opin Pulm Med"},{"key":"806_CR11","doi-asserted-by":"crossref","unstructured":"Dobra R, et al. Exploring the complexity of cystic fibrosis (CF) and psychosocial wellbeing in the 2020s: current and future challenges. Paediatr Respir Rev. 2024;54:35\u201342.","DOI":"10.1016\/j.prrv.2024.08.001"},{"issue":"7","key":"806_CR12","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1513\/AnnalsATS.202312-1065OC","volume":"21","author":"PR Burgel","year":"2024","unstructured":"Burgel PR, et al. Multisystemic effects of elexacaftor\u2013tezacaftor\u2013ivacaftor in adults with cystic fibrosis and advanced lung disease. Ann Am Thorac Soc. 2024;21(7):1053\u201364.","journal-title":"Ann Am Thorac Soc"},{"issue":"9","key":"806_CR13","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/ppul.26527","volume":"58","author":"CJ Bathgate","year":"2023","unstructured":"Bathgate CJ, et al. Positive and negative impacts of elexacaftor\/tezacaftor\/ivacaftor: healthcare providers\u2019 observations across US centers. Pediatr Pulmonol. 2023;58(9):2469\u201377.","journal-title":"Pediatr Pulmonol"},{"key":"806_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2024-002606","author":"M Harrigan","year":"2025","unstructured":"Harrigan M, et al. Psychosocial and mental health in cystic fibrosis in the modern era of care: time to evolve. BMJ Open Respir Res. 2025. https:\/\/doi.org\/10.1136\/bmjresp-2024-002606.","journal-title":"BMJ Open Respir Res"},{"issue":"6","key":"806_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/MCP.0000000000001014","volume":"29","author":"MB VanElzakker","year":"2023","unstructured":"VanElzakker MB, et al. Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort. Curr Opin Pulm Med. 2023;29(6):603\u20139.","journal-title":"Curr Opin Pulm Med"},{"key":"806_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1179208","volume":"14","author":"L Piehler","year":"2023","unstructured":"Piehler L, et al. Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on mental health of patients with cystic fibrosis. Front Pharmacol. 2023;14:1179208.","journal-title":"Front Pharmacol"},{"issue":"3","key":"806_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jcf.2023.01.015","volume":"22","author":"M Arslan","year":"2023","unstructured":"Arslan M, et al. Suicide attempts in adolescents with cystic fibrosis on elexacaftor\/tezacaftor\/ivacaftor therapy. J Cyst Fibros. 2023;22(3):427\u201330.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"806_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jcf.2024.07.008","volume":"24","author":"M Nguyen","year":"2025","unstructured":"Nguyen M, et al. Assessing the impact of elexacaftor\/tezacaftor\/ivacaftor on anxiety & depression symptom scores in adults with cystic fibrosis. J Cyst Fibros. 2025;24(1):26\u20139.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"806_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/17476348.2021.1855980","volume":"15","author":"PG Middleton","year":"2021","unstructured":"Middleton PG, Taylor-Cousar JL. Development of elexacaftor\u2013tezacaftor\u2013ivacaftor: highly effective CFTR modulation for the majority of people with cystic fibrosis. Expert Rev Respir Med. 2021;15(6):723\u201335.","journal-title":"Expert Rev Respir Med"},{"key":"806_CR20","first-page":"3","volume":"42","author":"IM Balfour-Lynn","year":"2022","unstructured":"Balfour-Lynn IM, King JA. CFTR modulator therapies\u2014effect on life expectancy in people with cystic fibrosis. Paediatr Respir Rev. 2022;42:3\u20138.","journal-title":"Paediatr Respir Rev"},{"issue":"1","key":"806_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jcf.2022.08.018","volume":"22","author":"I Fajac","year":"2023","unstructured":"Fajac I, et al. Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor\/tezacaftor\/ivacaftor. J Cyst Fibros. 2023;22(1):119\u201323.","journal-title":"J Cyst Fibros"},{"key":"806_CR22","doi-asserted-by":"crossref","unstructured":"Van Citters AD, et al. Wellness in the modulator era: an observational study of the impact of CFTR modulator therapy on the well-being of people with cystic fibrosis. J Cyst Fibros. 2024;24:642\u201351.","DOI":"10.1016\/j.jcf.2024.06.010"},{"key":"806_CR23","volume-title":"The analysis of the self","author":"H Kohut","year":"1971","unstructured":"Kohut H. The analysis of the self. New York: International Universities Press; 1971."},{"key":"806_CR24","first-page":"51","volume":"1","author":"R Cr.","year":"1959","unstructured":"Cr. R. The essence of psychotherapy: a client-centred view. Ann Psycho. 1959;1:51\u20137.","journal-title":"Ann Psycho"},{"issue":"2","key":"806_CR25","first-page":"198","volume":"18","author":"H Tajfel","year":"1979","unstructured":"Tajfel H. Individuals and groups in social psychology. Br J Clin Psychol. 1979;18(2):198\u2013190.","journal-title":"Br J Clin Psychol"},{"key":"806_CR26","volume-title":"Personality: contemporary theory and research","author":"R Baumeister","year":"2005","unstructured":"Baumeister R. Personality: contemporary theory and research. Belmont: Thomson\/Wadsworth; 2005."},{"issue":"1","key":"806_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev.ps.38.020187.001503","volume":"38","author":"H Markus","year":"1987","unstructured":"Markus H, Wurf E. The dynamic self-concept: a social psychological perspective. Ann Rev Psychol. 1987;38(1):299\u2013337.","journal-title":"Ann Rev Psychol"},{"issue":"3","key":"806_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3102\/00346543046003407","volume":"46","author":"RJ Shavelson","year":"1976","unstructured":"Shavelson RJ, Hubner J, Stanton GC. Self-concept: Validation of construct interpretations. Rev Educ Res. 1976;46(3):407\u201341.","journal-title":"Rev Educ Res"},{"issue":"10","key":"806_CR29","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/pon.5483","volume":"29","author":"E Butler","year":"2020","unstructured":"Butler E, et al. Self-concept and health anxiety relate to psychological outcomes for BRCA1\/2 carriers. Psychooncology. 2020;29(10):1638\u201345.","journal-title":"Psychooncology"},{"key":"806_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jad.2019.11.012","volume":"262","author":"E Hards","year":"2020","unstructured":"Hards E, et al. Negative view of the self and symptoms of depression in adolescents. J Affect Disord. 2020;262:143\u20138.","journal-title":"J Affect Disord"},{"issue":"8","key":"806_CR31","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1177\/1359105319871639","volume":"26","author":"L Kiropoulos","year":"2021","unstructured":"Kiropoulos L, Ward N, Rozenblat V. Self-concept, illness acceptance and depressive and anxiety symptoms in people with multiple sclerosis. J Health Psychol. 2021;26(8):1197\u2013206.","journal-title":"J Health Psychol"},{"key":"806_CR32","doi-asserted-by":"crossref","unstructured":"Morales-Sanchez L, et al. Enhancing self-esteem and body image of breast cancer women through interventions: a systematic review. Int J Environ Res Public Health. 2021;18(4):1640.","DOI":"10.3390\/ijerph18041640"},{"issue":"2","key":"806_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/0044118X20910938","volume":"53","author":"J Norrington","year":"2021","unstructured":"Norrington J. Adolescent peer victimization, self-concept, and psychological distress in emerging adulthood. Youth Soc. 2021;53(2):273\u201395.","journal-title":"Youth Soc"},{"key":"806_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s10880-024-10023-7","author":"M Harrigan","year":"2024","unstructured":"Harrigan M, et al. Who am I? Self-concept in adults with cystic fibrosis: association with anxiety and depression. J Clin Psychol Med Settings. 2024. https:\/\/doi.org\/10.1007\/s10880-024-10023-7.","journal-title":"J Clin Psychol Med Settings"},{"issue":"5","key":"806_CR35","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/ppul.26916","volume":"59","author":"M Harrigan","year":"2024","unstructured":"Harrigan M, et al. Me, myself, and I: a systematic review of cystic fibrosis and self-concept. Pediatr Pulmonol. 2024;59(5):1175\u201395.","journal-title":"Pediatr Pulmonol"},{"key":"806_CR36","volume-title":"Tennessee self-concept scale: TSCS-2","author":"WH Fitts","year":"1996","unstructured":"Fitts WH, Warren WL. Tennessee self-concept scale: TSCS-2. Los Angeles: Western Psychological Services; 1996."},{"issue":"10","key":"806_CR37","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3109\/09638288.2010.514017","volume":"33","author":"ME Gannotti","year":"2011","unstructured":"Gannotti ME, et al. Self-concept of adults with cerebral palsy. Disabil Rehabil. 2011;33(10):855\u201361.","journal-title":"Disabil Rehabil"},{"key":"806_CR38","volume-title":"The foundation of social research: meaning and perspective in the research process","author":"M Crotty","year":"1998","unstructured":"Crotty M. The foundation of social research: meaning and perspective in the research process. Thousand Oaks: Sage Publications; 1998."},{"key":"806_CR39","volume-title":"Researching health: qualitative, quantitative and mixed methods","author":"J Low","year":"2019","unstructured":"Low J. Unstructured and semi-structured interviews in health research. In: Researching health: qualitative, quantitative and mixed methods. London: Sage publications; 2019."},{"key":"806_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/0147-1767(85)90062-8","volume-title":"Naturalistic inquiry","author":"YS Lincoln","year":"1985","unstructured":"Lincoln YS, Guba E. Naturalistic inquiry. London: Sage; 1985."},{"key":"806_CR41","volume-title":"Researching lived experience: human science for an action sensitive pedagogy","author":"M Van Manen","year":"1990","unstructured":"Van Manen M. Researching lived experience: human science for an action sensitive pedagogy. Albany: State University of New York Press; 1990."},{"issue":"1","key":"806_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jcf.2024.11.003","volume":"24","author":"RS Everhart","year":"2025","unstructured":"Everhart RS, et al. What does it mean to be \u201chealthy\u201d when taking elexacaftor\/tezacaftor\/ivacaftor (ETI)? A qualitative study. J Cyst Fibros. 2025;24(1):187\u201392.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"806_CR43","doi-asserted-by":"publisher","first-page":"2062820","DOI":"10.1080\/17482631.2022.2062820","volume":"17","author":"M Harrigan","year":"2022","unstructured":"Harrigan M, et al. Living with cystic fibrosis during the COVID-19 pandemic: a social connectedness perspective. Int J Qual Stud Health Well-being. 2022;17(1):2062820.","journal-title":"Int J Qual Stud Health Well-being"},{"issue":"5","key":"806_CR44","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jcf.2023.03.011","volume":"22","author":"JE Snowball","year":"2023","unstructured":"Snowball JE, et al. A paradigm shift in cystic fibrosis nutritional care: clinicians\u2019 views on the management of patients with overweight and obesity. J Cyst Fibros. 2023;22(5):836\u201342.","journal-title":"J Cyst Fibros"},{"key":"806_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/nu14040834","author":"RM Bass","year":"2022","unstructured":"Bass RM, Tindall A, Sheikh S. Utilization of the healthy eating index in cystic fibrosis. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14040834.","journal-title":"Nutrients"},{"issue":"1","key":"806_CR46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bodyim.2011.09.001","volume":"9","author":"S Tierney","year":"2012","unstructured":"Tierney S. Body image and cystic fibrosis: a critical review. Body Image. 2012;9(1):12\u20139.","journal-title":"Body Image"},{"issue":"11","key":"806_CR47","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1002\/ppul.26102","volume":"57","author":"AP Kass","year":"2022","unstructured":"Kass AP, et al. Eating disorders in adolescents and young adults with cystic fibrosis. Pediatr Pulmonol. 2022;57(11):2791\u20137.","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"806_CR48","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jcf.2022.11.006","volume":"22","author":"AP Kass","year":"2023","unstructured":"Kass AP, et al. Clinician perspectives on assessing for disordered eating and body image disturbance in adolescents and young adults with cystic fibrosis. J Cyst Fibros. 2023;22(3):431\u20135.","journal-title":"J Cyst Fibros"},{"key":"806_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11111637","author":"RM Giron","year":"2022","unstructured":"Giron RM, et al. Longitudinal study of therapeutic adherence in a cystic fibrosis unit: identifying potential factors associated with medication possession ratio. Antibiotics. 2022. https:\/\/doi.org\/10.3390\/antibiotics11111637.","journal-title":"Antibiotics"},{"key":"806_CR50","doi-asserted-by":"publisher","DOI":"10.1177\/17534666241235054","volume":"18","author":"C Blardone","year":"2024","unstructured":"Blardone C, et al. Perceived burden of respiratory physiotherapy in people with cystic fibrosis taking elexacaftor-tezacaftor-ivacaftor combination: a 1-year observational study. Ther Adv Respir Dis. 2024;18:17534666241235054.","journal-title":"Ther Adv Respir Dis"},{"issue":"3","key":"806_CR51","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jcf.2024.02.003","volume":"23","author":"SH Donaldson","year":"2024","unstructured":"Donaldson SH, et al. The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor\/tezacaftor\/ivacaftor treated people with cystic fibrosis: the SIMPLIFY-MCC study. J Cyst Fibros. 2024;23(3):457\u201360.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"806_CR52","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jcf.2022.12.007","volume":"22","author":"F Milo","year":"2023","unstructured":"Milo F, et al. Lived experiences of people with cystic fibrosis that were not eligible for elexacaftor\u2013tezacaftor\u2013ivacaftor (ETI): a qualitative study. J Cyst Fibros. 2023;22(3):414\u20139.","journal-title":"J Cyst Fibros"},{"issue":"5","key":"806_CR53","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/ppul.25859","volume":"57","author":"E Kramer-Golinkoff","year":"2022","unstructured":"Kramer-Golinkoff E, et al. A survey: understanding the health and perspectives of people with CF not benefiting from CFTR modulators. Pediatr Pulmonol. 2022;57(5):1253\u201361.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"806_CR54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/02673843.2021.1899946","volume":"26","author":"DO Shemesh","year":"2021","unstructured":"Shemesh DO, Heiman T. Resilience and self-concept as mediating factors in the relationship between bullying victimization and sense of well-being among adolescents. Int J Adolesc Youth. 2021;26(1):158\u201371.","journal-title":"Int J Adolesc Youth"},{"key":"806_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191610377","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, et al. The relationship between self-concept and negative emotion: a moderated mediation model. Int J Environ Res Public Health. 2022. https:\/\/doi.org\/10.3390\/ijerph191610377.","journal-title":"Int J Environ Res Public Health"},{"key":"806_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.747168","volume":"12","author":"I Garcia-Martinez","year":"2021","unstructured":"Garcia-Martinez I, et al. Self-concept as a mediator of the relation between University students\u2019 resilience and academic achievement. Front Psychol. 2021;12:747168.","journal-title":"Front Psychol"},{"issue":"1","key":"806_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1027\/1016-9040\/a000124","volume":"18","author":"D Fletcher","year":"2013","unstructured":"Fletcher D, Sarkar M. Psychological resilience: a review and critique of definitions, concepts and theory. Eur Psychol. 2013;18(1):12\u201323.","journal-title":"Eur Psychol"},{"issue":"1","key":"806_CR58","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcf.2020.11.013","volume":"20","author":"CV O\u2019Hayer","year":"2021","unstructured":"O\u2019Hayer CV, et al. ACT with CF: a telehealth and in-person feasibility study to address anxiety and depressive symptoms among people with cystic fibrosis. J Cyst Fibros. 2021;20(1):133\u20139.","journal-title":"J Cyst Fibros"},{"key":"806_CR59","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00535-2022","author":"E van der Heijden","year":"2023","unstructured":"van der Heijden E, et al. The RISE study protocol: resilience impacted by positive stressful events for people with cystic fibrosis. ERJ Open Res. 2023. https:\/\/doi.org\/10.1183\/23120541.00535-2022.","journal-title":"ERJ Open Res"},{"issue":"4","key":"806_CR60","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.chest.2023.10.043","volume":"165","author":"S Graziano","year":"2024","unstructured":"Graziano S, et al. Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor: multidimensional assessment of neuropsychological side effects and physical and mental health outcomes in adolescents and adults. Chest. 2024;165(4):800\u20139.","journal-title":"Chest"},{"key":"806_CR61","doi-asserted-by":"crossref","unstructured":"Smith BA, Georgiopoulos AM, He J, Chaudary N, Wei R, Canda E, Nowakowski AX, Tillman L, Quittner AL. Development of the General Mental Health Screener (GEMS-CF): preliminary sampling and thematic analysis of mental health concerns in a diverse group of adults with cystic fibrosis. InL The North American Cystic Fibrosis Conference (NACFC). Boston: Journal of Cystic Fibrosis; 2024.","DOI":"10.1016\/S1569-1993(24)00123-1"},{"key":"806_CR62","unstructured":"Miles MB, Huberman AM, Salda\u00f1a J. Qualitative data analysis: A methods sourcebook. 3rd ed. Thousand Oaks, CA: SAGE Publications; 2013."}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-026-00806-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-026-00806-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-026-00806-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:08:08Z","timestamp":1787670488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40271-026-00806-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["806"],"URL":"https:\/\/doi.org\/10.1007\/s40271-026-00806-5","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Maggie Harrigan reports receipt of speaking and lecture honorarium from Vertex Pharmaceuticals outside of this research project. Siobhain Mulrennan reports her role as Principal Investigator for Vertex Pharmaceuticals CFTR modulator clinical trials and speaker honorarium from Vertex Pharmaceuticals outside of this research project. Melanie Jessup reports receipt of payment from Vertex Pharmaceuticals for consultancy as part of an independent working group outside of this research project. Kellie Bennett,Phoebe Waters, and Eleni Bacopanos declare no conflicts of interest relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the University of Western Australia (UWA) Human Research Ethics Committee (Ref: 2021\/ET000534).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No individual data or images shared.","order":3,"name":"Ethics","label":"Specific consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A full data set of statistical analysis and outputs relating to this paper is held by the corresponding author and can be made available upon request. Not all original data will be shared, in order to protect the privacy of research participants.","order":4,"name":"Ethics","label":"Data availability statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Maggie Harrigan was responsible for the study conceptualisation, investigation, formal analysis, and overall methodology, under the supervision of Dr. Kellie Bennett, Dr. Melanie Jessup, and Dr. Siobhain Mulrennan. Maggie Harrigan produced an original manuscript draft with input from all authors for manuscript revisions. Dr. Phoebe Waters and Dr. Eleni Bacopanos were responsible for data collection regarding physical health. All authors made a significant contribution, are responsible and accountable for the contents of this article, and have approved the final manuscript and choice of journal submission.","order":5,"name":"Ethics","label":"Author contribution statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}